CEO Thomas Hogan sold 103,188 shares of CLBT at $15.76; retains 590,777 shares (590.8K)
CEO Thomas E. Hogan sold 103,188 shares at $15.76 on 2026-07-02, reducing his holdings by 14.9% from 693,965 to 590,777 shares. The sale occurred when the stock was trading $15.76, while the current price stands at $16.61 and the 52-week high reached $19.98. The timing is notable given recent momentum—the stock gained 20.3% over the past 30 days and 17.4% over 90 days—suggesting the CEO liquidated a meaningful portion of his stake during a period of upward price movement. While the sale reduces his absolute exposure to Cellebrite, Hogan retains substantial holdings at a $4.1B market-cap company, and this single transaction alone does not establish a directional pattern without additional context on prior trading activity or board/corporate actions.